Related Experiment Video
Updated: Jun 21, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
Published on: May 31, 2024
Bioavailability of veterinary drugs in vivo and in silico
1Centre of Pharmacokinetics Research FILAB, Ravimed Sp. z o.o., Łajski, Poland. t.grabowski@filab.com.pl
Abstract:
The physical and chemical properties of a drug determine the behaviour of its molecule in a living organism. In this paper, the relationship between selected physical and chemical parameters and drug bioavailability in vivo was investigated. Data sets from 75 compounds, which can be administered per os to 11 various animal species were analyzed. The selected parameters for the prediction of the in vivo bioavailability were the lipophilicity (LogP) and the polar surface area (PSA) or apolar surface area (aPSA) of a molecule. It was shown that the calculation of the hybrid parameters aPSA/PSA and LogP + (aPSA/PSA) allows to estimate the oral bioavailability of a drug and its allocation to clusters with either an oral bioavailability of <70% or >70%. The performed analysis also showed that an extreme low value of the PSA of a molecule (<40 square ångströms) combined with the extreme high value of LogP (>4) is associated with a lower oral bioavailability (<50%). The results obtained indicate the existence of a relationship between the mean LogP value and aPSA/PSA in silico, and the bioavailability of veterinary drugs as determined in vivo.
More Related Videos
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
14:54An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Published on: October 20, 2018
Related Concept Videos
Modified-Release Drug Delivery Systems: Bioavailability
Drug Product Performance: In Vitro–In Vivo Correlation
Bioavailability: Overview
Bioavailability: Overview
Equivalence: In Vitro and In Vivo Bioequivalence
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems